Imprinted genes are regulated according to parental origin and can influence embryonic growth and metabolism and confer disease susceptibility. Here, we designed sensitive allele-specific reporters to noninvasively monitor imprinted Cdkn1c expression in mice and showed that expression was modulated by environmental factors encountered in utero. Acute exposure to chromatin-modifying drugs resulted in de-repression of paternally inherited (silent) Cdkn1c alleles in embryos that was temporary and resolved after birth. In contrast, deprivation of maternal dietary protein in utero provoked permanent de-repression of imprinted Cdkn1c expression that was sustained into adulthood and occurred through a folate-dependent mechanism of DNA methylation loss. Given the function of imprinted genes in regulating behavior and metabolic processes in adults, these results establish imprinting deregulation as a credible mechanism linking early-life adversity to later-life outcomes. Furthermore, Cdkn1c-luciferase mice offer non-invasive tools to identify factors that disrupt epigenetic processes and strategies to limit their long-term impact.
In Brief
Van de Pette et al. use sensitive allelespecific reporters to longitudinally image imprinted Cdkn1c expression in mice and show that expression is modulated by environmental factors encountered in utero. These results establish imprinting deregulation as a mechanism linking early-life adversity to later-life outcomes and provide tools to detect imprinting changes in vivo.
INTRODUCTION
Epigenetics is the study of heritable changes in gene expression that arise from non-genetic influences. Genomic imprinting is an epigenetic process found in eutherian and metatherian mammals that results in parent-of-origin-specific allelic expression (John and Surani, 2000) . A relatively small subset of genes within the mammalian genome (0.4%) is imprinted (Surani et al., 1984; McGrath and Solter, 1984) , and these show mono-allelic expression either universally or in specific tissues that favors the maternal (e.g., Cdkn1c and Ube3a) or the paternal allele (e.g., Dlk1 and Nnat; Monk et al., 2006) . Imprinted expression is initially determined by differential DNA methylation that is established in the germline (Surani, 1998) . Although the rationale for genomic imprinting remains uncertain, the critical role of imprinted genes in embryonic growth, placental development, and neurogenesis (Cleaton et al., 2014) suggests that imprinting may serve to balance the selective pressures between parental genomes and control in utero offspring demand (Wolf and Hager, 2006; Day and Bonduriansky, 2004; Haig, 2004) . Imprinted genes encode proteins that have a wide range of roles in nutrient transport, signaling, cell-cycle control, protein synthesis and degradation, and ion channel function. Their impact extends into postnatal life with key roles in the regulation of both metabolic and neuronal processes. Alterations at imprinted gene loci in humans are associated with rare disorders, such as Beckwith-Wiedemann syndrome (Lam et al., 1999) , and also more common pathological conditions, including mental disability, impaired neuro-behavioral function, diabetes, obesity, muscle hypertrophy, and also with cancer (Radford et al., 2011) .
Despite their importance, imprinted genes are particularly challenging to study. This in part reflects experimental difficulties that are common to mono-allelic genes, in that gene deletion experiments show all or nothing effects, whereas alterations in gene dosage can result in complex phenotypes in which isolating genetic and epigenetic traits is problematic (Cleaton et al., 2014; John, 2010) . In addition, imprinted genes are often clustered within genomic domains in which regulation is achieved through multiple levels of epigenetic control, including DNA methylation, non-coding RNAs, and modified histones (Bartolomei and Ferguson-Smith, 2011) . Finally, studies to assess the impact of chromatin-modifying drugs or environmental stress on imprinted gene expression require the maternal and paternal alleles to be discriminated on the basis of heterozygous SNPs or have used LacZ-based targeting of endogenous alleles (John, 2010) . Whereas such approaches provide valuable generic tools to examine imprint dynamics through development and in response to stress, the invasive nature of the allelic readout means that it is not feasible to longitudinally monitor imprinted gene expression in different individuals throughout their life course. Models using fluorescence-based reporters have provided non-invasive readouts at whole-body and single-cell resolution (Jones et al., 2011; Swanzey and Stadtfeld, 2016) , but tissue depth and sensitivity constraints may limit their general applicability. To provide new tools for investigating the consequences of early-life adversity, we generated a series of knockin embryonic stem cells (ESCs) and mouse lines in which firefly luciferase reports endogenous imprinted gene expression, and non-invasive bioluminescent imaging provides a means of monitoring expression longitudinally in vivo.
Cdkn1c is a maternally expressed imprinted gene that lies within the imprinting cluster 2 (IC2) on mouse chromosome 7 and is imprinted in both mice and humans (Hatada and Mukai, 1995; Hatada et al., 1996) . The gene encodes a cyclin-dependent kinase inhibitor that is transiently expressed during embryogenesis in cells exiting proliferation (Lee et al., 1995; Matsuoka et al., 1995) and is particularly abundant within neural and skeleto-muscular tissue around mid-gestation (Westbury et al., 2001) . Cdkn1c has an important role in regulating fetal growth and placental development (Andrews et al., 2007; Takahashi et al., 2000; Tunster et al., 2011) as well as lineage-specific roles, including in brown adipose tissue (Van De Pette et al., 2016) , skeletal muscle (Osborn et al., 2011) , and in adult quiescent stem cells (Zacharek et al., 2011; Matsumoto et al., 2011; Joseph et al., 2009) . Cdkn1c lies within a complex imprinted domain regulated by an imprinting center that acquires DNA methylation in the maternal germline (gametic DMR; KvDMR1; John and Lefebvre, 2011; Hatada and Mukai, 1995; Hatada et al., 1996; Mohammad et al., 2012) . This differentially methylated region spans the promoter of the paternally expressed long non-coding RNA Kcnq1ot1 required for continuous domain-wide imprinting. The Cdkn1c promoter and gene body are also directly DNA methylated on the paternal allele post-fertilization, after allelic silencing has been established (somatic DMR; Cdkn1c-sDMR [somatic differentially methylated region]; Bhogal et al., 2004) . Given the profound effect of modest dosage alteration of this gene on post-natal metabolic and behavioral processes (Andrews et al., 2007; Van De Pette et al., 2016; McNamara et al., 2016) , it provides an ideal candidate to study using sensitive allele-specific reporters.
RESULTS
Generating Luciferase-Based Allelic Reporters for Mouse Cdkn1c Mouse ESC lines were generated in which firefly luciferase (FLuc) alone, or in combination with b-galactosidase (FLucLacZ), was knocked into the endogenous Cdkn1c locus (Figures S1A and 1A, respectively) . In some of the resulting targeted clones, lowlevel bioluminescence was detected after adding the luciferase substrate D-luciferin, consistent with insertion of luciferase into the maternal allele in selected clones ( Figure 1B, blue) . Upon differentiation, we observed increased expression of Cdkn1c (Figures 1C, left, and S1B, left) , as anticipated from previous studies (Wood et al., 2010) . In clones with a presumed maternal insertion, increased Cdkn1c expression was coupled to a corresponding increase in luciferase expression (Figures 1C and S1B Figure 1D ). Strikingly, pregnant females carrying embryonic day 11.5 (E11.5) Cdkn1c-FLucLacZ KI mat embryos (14/14), but not KI pat embryos (0/10), showed a strong bioluminescent signal in the abdominal region ( Figure 1E , upper). On dissection, transgenic embryos and placenta carrying the maternal targeted allele appropriately expressed luciferase, whereas those carrying the paternal targeted allele show no bioluminescence ( Figure 1E , lower). Similar results were obtained with Cdkn1c-FLuc mice ( Figure S1C ). Figure S1D ) confirmed spatially appropriate expression in the hindbrain, spine, and developing cartilage, consistent with the published distribution of Cdkn1c (Westbury et al., 2001 ). This was further verified by 3D imaging using optical projection tomography (OPT) of cleared embryos (Figure S1D, lower; Movie S1), combined with photoacoustic tomography ( Figure S1E ). Importantly, no staining was detected in KI pat embryos by this sensitive approach, confirming global repression of the paternal allele. Consistent with this, luciferase mRNA was only detectable after maternal inheritance ( Figure 1F ) alongside wild-type levels of the Cdkn1c transcript. Amplification with a primer set that spanned Cdkn1c exon 3 and luciferase exon 1 confirmed linked expression of luciferase and endogenous Cdkn1c transcripts ( Figure 1F ). Bisulfite analysis of the two differentially methylated regions associated with Cdkn1c imprinting (Bhogal et al., 2004; Mancini-Dinardo et al., 2006) showed normal DNA methylation patterns in heads of Cdkn1c-FLucLacZ KI mat embryos ( Figure 1G ). Collec- tively, these data indicate that luciferase accurately reports Cdkn1c expression without impairing the methylation or regulation of the endogenous locus.
Imprinted Cdkn1c-FlucLacZ Expression Is Appropriately Reset through the Germline Epigenetic marks that establish and maintain imprinting are normally erased and reset in the germline so that allelic expression is correctly maintained in subsequent generations (Bartolomei and Ferguson-Smith, 2011) . To check whether erasure and resetting of imprints occurred normally in the luciferase-targeted mice, we tracked bioluminescence (blue) among reciprocal genetic crosses of Cdkn1c-FLucLacZ (gray) and wild-type mice (white) across generations (Figure 2A ; F1, F2, and F3). Tracing bioluminescence activity across three generations revealed epigenetic inheritance as predicted (Figures 2B and 2C) , in which allelic silencing of Cdkn1c-FLucLacZ was reversed through maternal transmission and re-established through paternal transmission. The ability to image Cdkn1c expression longitudinally in vivo through successive generations suggested that these reporter mice might be useful and robust models to screen for factors and environmental stresses that could interfere with imprinting. Importantly, as female mice inheriting Cdkn1c-FLucLacZ paternally (KI pat ; left box, Figure 2B) were devoid of luciferase signal, these animals offered an optimal setting (minimal background) to detect bioluminescence signals in utero from KI mat embryos and placental tissue ( Figures   1E , left, and 2C).
Cell Reports 18, 1090-1099, January 31, 2017 1093 Chromatin-Modifying Drugs Transiently Disrupt Paternal Silencing of Cdkn1c In Utero 5 0 azacytidine (5 0 Aza) disrupts DNA methylation in cells by inhibiting DNMT1 activity, thereby preventing the incorporation of 5-methylcytosine into hemi-methylated DNA strands at S phase. In dividing cells in culture, 5 0 Aza treatment has been shown to reduce DNA methylation at the Cdkn1c promoter (Flotho et al., 2009) . Trichostatin A (TSA) inhibits histone deacetylase activity and has been shown to deplete repressive histone marks at the Cdkn1c promoter (Yang et al., 2009) . We reasoned that drugs that alter chromatin, such as 5 0 Aza and TSA, might be effective at disrupting Cdkn1c expression when epigenetic marks are consolidated (Bhogal et al., 2004; Umlauf et al., 2004) . To examine this possibility, wild-type female mice were crossed with homozygous Cdkn1c-FLucLacZ (KI/KI) males to produce heterozygous offspring in which the Cdkn1c-FLucLacZ imprint was repressed. The pregnant females were then treated with drugs at E12.5-E13.5, and bioluminescence was evaluated at E14.5, at birth (P1), and at 4 weeks of age (postnatal day 28 [P28]; Figure 3A ). Bioluminescence was detected in utero at E14.5 with strongest signal seen following combined drug treatment (Combi) ( Figure 3B ). Control vehicle-treated KI pat embryos were consistently negative throughout these studies. For 5 0 Aza-(3/9) and TSA-treated (4/9) pregnancies, bioluminescence was not detected in all the transgenic embryos, whereas all the transgenic embryos (7/7) displayed increased luciferase activity upon combination treatment ( Figure 3C ). These animals showed a corresponding decrease in DNA methylation across the Cdkn1c somatic DMR at E14.5 as compared with controls ( Figure 3D ). We noticed that the levels of bioluminescence were generally lower than in age-matched Cdkn1c-FLucLacZ KI mat embryos, consistent with partial de-repression of the paternal allele. Furthermore, de-repression appeared transient and was variable among combination drug-treated animals, as shown in pups imaged at birth (P1; Figure 3E ). Four weeks after birth (P28), bioluminescence signal was no longer evident in drug-treated KI pat animals ( Figure 3F ), and DNA methylation in the brain was similar in vehicle-and Combi-treated Cdkn1c-FLucLacZ KI pat mice ( Figure 3G ). Taken together, these data show that conventional chromatin-modifying drugs alone or in combination are capable of relieving imprinted Cdkn1c-FLucLacZ repression in developing embryos.
Dietary Protein Restriction In Utero Provokes Derepression of Paternal Cdkn1c into Adulthood
Cdkn1c has previously been proposed to be sensitive to in utero dietary protein restriction (Vucetic et al., 2010) . In particular, mice that were fed a low-protein diet through pregnancy (as a surrogate for early-life adversity) produced offspring with elevated levels of Cdkn1c in the midbrain associated with DNA hypomethylation at the promoter. To examine whether exposure to low-protein diet in utero provokes de-repression of the silent paternal Cdkn1c-FLucLacZ, we crossed wild-type female mice with heterozygous Cdkn1c-FLucLacZ (WT/KI) males ( Figure 4A , schematic). Pregnant mice were fed calorie-balanced, low-protein diet (LP) from the detection of vaginal plugs until birth. All newborn offspring were maintained thereafter on a normal (unrestricted) diet. This window of exposure ensures that the influence of LP diet is restricted to a specific period of development. Although bioluminescence signal was not detected at E11.5 ( Figure S2 ), by E14.5, all Cdkn1c-FLucLacZ KI pat embryos expressed luciferase following maternal exposure to low-protein diet (exemplified in Figure 4A , middle right). Signal was most pronounced in the head, and luciferase re-expression among KI pat embryos was prominent in the midbrain region ( Figure S3 ). De-repression was sustained in mice imaged subsequently at 4 weeks of age ( Figure 4A , lower right) and throughout adulthood, despite no longer being exposed to a restricted diet. These data establish that in utero exposure to a low-protein diet results in permanent de-repression of the normally silent paternal allele. To further explore the mechanism underlying Cdkn1c re-expression, we compared DNA methylation in the brain at E11.5, E14.5, and in adults at 4 weeks of age ( Figure 4B ). Appropriate DNA methylation at the somatic DMR was evident at E11.5, when no luciferase activity was detected ( Figure S2 ), but this was progressively eroded in animals exposed to LP diet during gestation ( Figure 4B ). These data show that, under these conditions, the somatic DMR is established correctly, but not maintained, suggesting that dietary protein may be required to sustain DNA methylation at the paternal allele. In contrast, DNA methylation at KvDMR1 was unaffected by LP diet (Figure 4B) , consistent with previous reports (Ivanova et al., 2012) .
Rescue of Dietary-Induced Loss of Paternal Cdkn1c
Silencing by Folate Supplementation As dietary protein is known to be an important source of methyl donors required for DNA methylation, we hypothesized that a paucity of methyl donors might contribute to the failure to sustain repression of Cdkn1c pat alleles in vivo. To test this, we repeated the dietary experiments using the low-protein diet with increased folate supplementation as a source of methyl donors. This had a dramatic effect, reducing paternal Cdkn1c-FLucLacZ bioluminescence to background levels in embryos ( Figure 4C , left) and in resulting adults ( Figure 4C , right). We also found that, following folate supplementation, methylation of Cdkn1c somatic DMR (B) Low-level bioluminescence was occasionally detected in 5 0 Aza-and TSA-alone treated pregnancies, whereas stronger and consistent signal (blue) was detected in combination-treated (Combi) embryos in utero (left) or individually dissected embryos (right) in the head and back.
(C) Cdkn1c-FLucLacZ-derived bioluminescent activity was consistently elevated in E14.5 embryos exposed to combined drug treatment. was indistinguishable from normal controls ( Figures 4B and 4D ).
De-repression and restoration of Cdkn1c-FlucLacZ silencing in response to LP and LP + folate diet, respectively, was directly validated by allele-specific transcript analysis ( Figure 4E ). Thus, although previous studies have shown Cdkn1c upregulation in response to LP diet (Vucetic et al., 2010) , our data now establish that dietary restriction can cause loss of imprinting.
DISCUSSION
In utero development is critically dependent on imprinted gene dose (Radford et al., 2011) . This necessary control has been shown to extend into the programming of adult metabolism (Da Rocha et al., 2009; Charalambous et al., 2012) . Here, we show that maternal dietary restriction has a profound impact on Cdkn1c expression in the embryo, provoking a partial loss of imprinting that persists through adult life, even when a normal diet is resumed. Prolonged exposure to low-protein diet during gestation erodes DNA methylation at the Cdkn1c somatic DMR and results in re-expression of the paternal allele. Because deregulation is rescued by elevated folate supplementation, methyl donor deprivation appears to be the most likely cause of imprint erosion. Although we do not yet know whether this reflects a specific window of vulnerability in embryonic development or simply an increased demand engendered by proliferating cells in the embryo, the observation that the gametic KvDMR1 DMR resists DNA de-methylation supports previous findings that gametic differentially methylated regions (gDMRs) are relatively stable (Ivanova et al., 2012) . Mechanistically, gametic and somatic DMRs both require the maintenance of DNA methylation by DNMT1 (Caspary et al., 1998; Bhogal et al., 2004) . However, whereas zygotic deficiency of the de novo methylases Dnmt3a or 3b has no effect on gDMR methylation, loss of Dnmt3b results in de-methylation of Cdkn1c-sDMR independent of KvDMR1 status (Auclair et al., 2014) . These data provide a precedent for the differential sensitivities of the gametic and somatic DMRs and implicate Dnmt3b as a candidate in preventing hypo-methylation at the Cdkn1c sDMR. Imprinted genes are pivotal for regulating growth and metabolism, and yet the intricacies of imprinting have remained challenging to study. This reflects the intrinsic complexity of imprinting control regions (ICRs) but also a paucity of markers needed to reliably distinguish maternal from paternal alleles. Here, we describe two independent mouse lines in which luciferase-based bioluminescence reports allelic Cdkn1c expression, without disruption of endogenous gene output. The value of using this non-invasive approach is that it allows allelic expression to be imaged in individuals throughout life course so that epigenetic changes and their consequences can be evaluated directly. The close correspondence of luciferase expression in Cdkn1c-FLuc and Cdkn1c-FLucLacZ mouse lines suggests similar approaches might also be useful in studying allelic expression from other imprinted loci. Consistent with this idea, we have generated a series of ESC lines that report maternally expressed (Ube3a) or paternally expressed imprinted genes (Dlk1, Nnat, and Igf2) and are characterizing luciferase expression in mouse lines derived from such (Table S1 ). These lines, together with the Cdkn1c-FLucLacZ and Cdkn1c-FLuc lines described herein, provide novel genetic tools to interrogate the epigenetic mechanisms that establish, maintain, and reprogram imprinted gene expression in the female and the male germlines.
The observation that the Cdkn1c imprint is permanently disrupted by altered maternal diet provides a clear link between early-life adversity and the subsequent epigenetic mis-regulation in adult life. Our results suggest that a deficiency in methyl donor supply in utero is the most likely cause of imprint disruption, whereas limited exposure to well-characterized chromatin-modifying drugs in utero transiently deregulates imprint silencing. The basis of these different epigenetic outcomes is interesting and could reflect differences in the timing or length of exposure, inherent differences in cell proliferation, or the susceptibility of developing tissue to certain agents. Although future studies will be required to discriminate these possibilities, our ability to detect transient and permanent changes in imprint silencing in vivo offers an exciting new opportunity to explore the plasticity of epigenetic processes and their phenotypic outcome. More broadly, these luciferase-based imaging models will facilitate the rapid screening of epigenetic drugs and environmental stresses relevant for drug discovery programs and for understanding how epigenome deregulation in early life impacts upon longer-term health.
EXPERIMENTAL PROCEDURES Animal Maintenance
Mice were handled and all in vivo studies were performed in accordance with the United Kingdom Animals (Scientific Procedures) Act (1986), were mis-expression of luciferase was observed at day E11.5 ( Figure S2 ), irrespective of diet; however, by E14.5, luciferase activity was detected selectively in embryos of mothers fed LP diet (upper right) and expression continued as these matured into adults (lower right). No signal was detected in animals fed normal (control) diet at any time. Figure 1A ). Cdkn1c-FLucLacZ KI pat embryos were generated as in Figure 4A , with mothers receiving either normal (control) or low protein (LP) diet throughout pregnancy. Luciferase activity remained low in all Cdkn1c-FLucLacZ KI pat embryos at E11.5, consistent with correct imprinting of the paternal allele at this stage. 
